Skip to main content
Erschienen in: World Journal of Surgery 3/2012

01.03.2012

Log Odds of Positive Lymph Nodes in Colon Cancer: A Meaningful Ratio-based Lymph Node Classification System

verfasst von: Roberto Persiani, Ferdinando C. M. Cananzi, Alberto Biondi, Giuseppe Paliani, Andrea Tufo, Francesco Ferrara, Vincenzo Vigorita, Domenico D’Ugo

Erschienen in: World Journal of Surgery | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The log odds of positive lymph nodes (LODDS), defined as the log of the ratio between the numbers of positive and negative lymph nodes, has recently been proposed as a new prognostic index in surgical oncology. The aim of the present study was to investigate whether the LODDS system of lymph node classification was a more accurate prognostic tool than the tumor node metastasis (TNM) and lymph node ratio (LNR) classifications in colon cancer patients.

Materials and methods

Clinicopathologic data from 258 colon cancer patients who had undergone surgical resection were reviewed. Lymph node parameters were categorized according to the Internation Union Against Cancer/American Joint Cancer Commission (UICC/AJCC) TNM staging system, the LNR (LNR0 with ratio ≤ 0.05, LNR1 with 0.05 < ratio ≤ 0.20, LNR2 with ratio > 0.20), and the log odds ratio (LODDS0 ≤ –1.36, –1.36 < LODDS1 ≤ –0.53, and LODDS2 > –0.53).

Results

The LODDS was able to identify patients who would have been included in different prognostic categories, according to both the TNM and LNR. In addition, LODDS was significantly related to the number of positive and negative lymph nodes, as well as the number of examined lymph nodes. In multivariate analysis, LODDS classification (LODDS0: HR 1; LODDS1: HR 3.687, p = 0.003; LODDS2: HR 9.440, p < 0.001) was identified as an independent prognostic factor.

Discussion

The LODDS system is a highly reliable staging system with strong predictive ability for patient outcome. Compared with other nodal staging systems, the prognostic power of LODDS is less influenced by the number of lymph nodes dissected and examined.
Literatur
1.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York
2.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind CH (2009) UICC TNM classification of malignant tumors, 7th edn. Wiley, New York Sobin LH, Gospodarowicz MK, Wittekind CH (2009) UICC TNM classification of malignant tumors, 7th edn. Wiley, New York
3.
Zurück zum Zitat Wang J, Kulayat MN, Rockette H et al (2009) Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg 249:559–563PubMedCrossRef Wang J, Kulayat MN, Rockette H et al (2009) Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg 249:559–563PubMedCrossRef
4.
Zurück zum Zitat Johnson PM, Porter GA, Ricciardi R et al (2006) Increasing negative lymph node count is independently associated with improved long term survival stage IIIB and IIIC colon cancer. J Clin Oncol 24:3570–3575PubMedCrossRef Johnson PM, Porter GA, Ricciardi R et al (2006) Increasing negative lymph node count is independently associated with improved long term survival stage IIIB and IIIC colon cancer. J Clin Oncol 24:3570–3575PubMedCrossRef
5.
Zurück zum Zitat Rosenberg R, Engel J, Bruns C et al (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251:1070–1078PubMedCrossRef Rosenberg R, Engel J, Bruns C et al (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251:1070–1078PubMedCrossRef
6.
Zurück zum Zitat Ricciardi R, Madoff RD, Rothenberger DA et al (2006) Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 4:1522–1527PubMedCrossRef Ricciardi R, Madoff RD, Rothenberger DA et al (2006) Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 4:1522–1527PubMedCrossRef
7.
Zurück zum Zitat Sun Z, Xu Y, de Li M et al (2010) Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 116:2571–2580PubMedCrossRef Sun Z, Xu Y, de Li M et al (2010) Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 116:2571–2580PubMedCrossRef
8.
Zurück zum Zitat Vinh-Hung V, Verschraegen C, Promish DI et al (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6:R680–R688PubMedCrossRef Vinh-Hung V, Verschraegen C, Promish DI et al (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6:R680–R688PubMedCrossRef
9.
Zurück zum Zitat Wang J, Hassett JM, Dayton MT et al. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12:1790–1796 Wang J, Hassett JM, Dayton MT et al. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12:1790–1796
10.
11.
Zurück zum Zitat Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712PubMedCrossRef Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712PubMedCrossRef
12.
Zurück zum Zitat Edler D, Ohrling K, Hallstrom M et al (2007) The number of analyzed lymph nodes—a prognostic factor in colorectal cancer. Acta Oncol 46:975–981PubMedCrossRef Edler D, Ohrling K, Hallstrom M et al (2007) The number of analyzed lymph nodes—a prognostic factor in colorectal cancer. Acta Oncol 46:975–981PubMedCrossRef
13.
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRef Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRef
14.
Zurück zum Zitat Jakub JW, Russell G, Tillman CL et al (2009) Colon cancer and low lymph node count. Who is to blame? Arch Surg 144:1115–1120PubMedCrossRef Jakub JW, Russell G, Tillman CL et al (2009) Colon cancer and low lymph node count. Who is to blame? Arch Surg 144:1115–1120PubMedCrossRef
15.
Zurück zum Zitat Ostadi MA, Harnish JL, Stegienko S et al (2007) Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 21:2142–2146PubMedCrossRef Ostadi MA, Harnish JL, Stegienko S et al (2007) Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 21:2142–2146PubMedCrossRef
16.
Zurück zum Zitat Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer. Ann Surg 244:602–610PubMed Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer. Ann Surg 244:602–610PubMed
17.
Zurück zum Zitat Mammen JMV, James LE, Molloy M et al (2007) The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 194:349–354PubMedCrossRef Mammen JMV, James LE, Molloy M et al (2007) The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 194:349–354PubMedCrossRef
18.
Zurück zum Zitat Reiman JM, Kmieciak M, Manjili MH et al (2007) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17:275–287PubMedCrossRef Reiman JM, Kmieciak M, Manjili MH et al (2007) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17:275–287PubMedCrossRef
19.
Zurück zum Zitat Dougan M, Dranoff G (2009) The immune response to tumors. Curr Protoc Immunol 20:1–4 Dougan M, Dranoff G (2009) The immune response to tumors. Curr Protoc Immunol 20:1–4
20.
Zurück zum Zitat Gonen M, Schrag D, Weiser MR (2009) Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 27:6166–6171PubMedCrossRef Gonen M, Schrag D, Weiser MR (2009) Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 27:6166–6171PubMedCrossRef
21.
Zurück zum Zitat Rosenberg R, Hoos A, Mueller J et al (2002) Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20:1049–1055PubMedCrossRef Rosenberg R, Hoos A, Mueller J et al (2002) Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20:1049–1055PubMedCrossRef
22.
Zurück zum Zitat Doekhie FS, Mesker WE, Kuppen PJ et al (2010) Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int J Cancer 126:2644–2652PubMed Doekhie FS, Mesker WE, Kuppen PJ et al (2010) Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int J Cancer 126:2644–2652PubMed
23.
Zurück zum Zitat Huh JW, Kim YJ, Kim HR (2010) Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol 17:2640–2646PubMedCrossRef Huh JW, Kim YJ, Kim HR (2010) Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol 17:2640–2646PubMedCrossRef
Metadaten
Titel
Log Odds of Positive Lymph Nodes in Colon Cancer: A Meaningful Ratio-based Lymph Node Classification System
verfasst von
Roberto Persiani
Ferdinando C. M. Cananzi
Alberto Biondi
Giuseppe Paliani
Andrea Tufo
Francesco Ferrara
Vincenzo Vigorita
Domenico D’Ugo
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 3/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1415-x

Weitere Artikel der Ausgabe 3/2012

World Journal of Surgery 3/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.